Clinical Trials · NCT04146155

Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease

UnknownPhase 4Liraglutide (Unclear)
Phase
Phase 4
Recruitment status
Unknown
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Enrollment
200
Start date
May 2020
Locations
1 site, China
Primary endpoint
Initial and absolute claudication distance
View Liraglutide compound reference